Navigation Links
Unilife Announces Chairman's Letter to Shareholders
Date:4/27/2011

iness so that we can drive sales of the Unifill syringe and accelerate the commercialization of other exciting products in our pipeline. As an additional benefit, this realignment of our operations will improve our cash flow by $12MM during the 2011 calendar year.

This strategic realignment is also designed to harness the maximum potential of a significant new and emerging opportunity for Unilife. Our streamlined business structure, dynamic team, automated production systems and stringent quality standards position us to progressively emerge as the preferred 'go-to' innovation partner for pharmaceutical companies seeking elegant device solutions that meet the specific needs of their therapeutic drugs and vaccines.

Traditionally, pharmaceutical and biotechnology companies have pinned their hopes on generating at least one blockbuster drug franchise out of dozens of development programs. This is like trying to hit one home run for every 30 or 40 strikes at the ball.  It is our understanding that many large pharmaceutical companies are now looking to spread their risk by directing R&D investment towards the development of a greater number of highly personalized therapeutic drugs that can be marketed into smaller patient-specific populations. This new wave of novel drugs and vaccines, such as biologics with a high molecular complexity, will typically need to be matched with equally specialized delivery devices that are custom-designed to meet the specific requirements of the drug, and its effective administration to the patient. Rather than trying to develop such customized devices in-house, pharmaceutical companies are looking to outsource these projects to industry specialists.

What these pharmaceutical and biotechnology companies desire most is an agile, efficient and highly responsive partner that can serve as a one-stop shop for device innovation. Unilife is uniquely positioned to accommodate these unmet pharmaceutical needs. We have
'/>"/>

SOURCE Unilife Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Unilife Realigns Operations to Drive Sales and Support Commercial Production of Unifill Syringes
2. Unilife Commences Initial Production of Unifill Prefilled Syringe
3. Unilife COO Makes Open Market Purchase of Approximately $250,000 in Companys Publicly Traded Shares
4. Unilife CEO Makes Open Market Purchase of A$500,000 in Companys Publicly Traded Shares
5. Unilife on Schedule to Fill Initial Orders for Unifill Syringe
6. Unilife to Present at the 31st Annual Cowen Health Care Conference on Wednesday, March 9, 2011 in Boston
7. Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter
8. Unilife Corporation to Announce Financial Results for Fiscal 2011 Second Quarter on Monday, February 14, 2011
9. Unilife Appoints Dr. Ramin Mojdeh as Chief Operating Officer
10. Unilife Receives SPP Applications Exceeding A$12.8 Million
11. Unilife Corporation Moves into New State-of-the-Art Manufacturing Facility and Global Headquarters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 5. März 2015 Unfors ... im Bereich diagnostische Röntgenstrahlung, stellte heute ... dem European Congress of Radiology (ECR) ... Österreich, einen neuen Strahlungsüberwachungssensor vor. ... Der RaySafe X2-Überwachungssensor ...
(Date:3/4/2015)...  The strongest driver of demand in the ... population, according to Kalorama Information. The finding was ... market research publisher, Global Orthopedic Device Market ... such as obesity is contributing to the rise ... designs and the trend toward cost effective solutions ...
(Date:3/4/2015)... GSI Group Inc. (NASDAQ: GSIG ... and supplier of precision photonics and motion control components ... technology markets, today reported financial results for the fourth ... financial results in this press release are GAAP measures ... fourth quarter of 2014, GSI generated revenue of $94.0 ...
Breaking Medicine Technology:Unfors RaySafe, ein Unternehmen von Fluke Biomedical, stellt auf European Congress of Radiology neuen Überwachungssensor vor 2Unfors RaySafe, ein Unternehmen von Fluke Biomedical, stellt auf European Congress of Radiology neuen Überwachungssensor vor 3Kalorama: Growing Elderly Population Drives Orthopedic Device Market 2Kalorama: Growing Elderly Population Drives Orthopedic Device Market 3GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 2GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 3GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 4GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 5GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 6GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 7GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 8GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 9GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 10GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 11GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 12GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 13GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 14GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 15GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 16GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 17GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 18GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 19GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 20GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 21GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 22GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 23GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 24GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 25GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 26GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 27GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 28GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 29GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 30GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 31GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 32
(Date:3/4/2015)... March 04, 2015 Imagine No Malaria’s 2014 ... Care2 Innovator Award , an honor given to nonprofit ... at the Nonprofit Technology Conference (NTC15) in Austin, ... United Methodist Church in Austin, was on hand for the ... Imagine No Malaria. , Imagine No Malaria was one of ...
(Date:3/4/2015)... The Asia-Pacific phthalic anhydride market is estimated ... 2019, at a CAGR of 5.9% during the ... through the TOC of Asia-Pacific Phthalic Anhydride Market ... with the help of various tables and figures., ... a derivative of phthalic acid, which is either ...
(Date:3/4/2015)... When people talk about venues being the ... across numerous genres, the Houston Rodeo will be ... during the annual livestock show and rodeo, one popular band ... activities being held at the event. The 2015 show will ... will try and get the festival its largest attendance ever. ...
(Date:3/4/2015)... The federal litigation established for Lipitor ... caused patients to develop Type 2 diabetes continues to ... South Carolina. According to court documents, the proceeding’s next ... at 10:00 a.m. In advance of the Conference, the ... report to the Court by March 19, 2015. (In ...
(Date:3/4/2015)... FDA’s New Inspection Approach:, What Your ... 24, 2015 — 1:30 p.m. – 3:00 p.m. EDT, ... four hours of an inspection whether a manufacturer’s in ... “good” list, they’ll merely ask for reassurance that they ... the “bad” list, the manufacturer must get ready to ...
Breaking Medicine News(10 mins):Health News:Imagine No Malaria Receives Care2 Innovator Award 2Health News:Imagine No Malaria Receives Care2 Innovator Award 3Health News:The Asia-Pacific Ohthalic Anhydride Market is Estimated to Reach $5,632.8 Million by 2019 - A Report by MicroMarket Monitor 2Health News:The Asia-Pacific Ohthalic Anhydride Market is Estimated to Reach $5,632.8 Million by 2019 - A Report by MicroMarket Monitor 3Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 2Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 3Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 2Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 2Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 4
... a leader in the,DHA omega-3 food and supplements ... be expanding its reach in the animal feed,market ... DHA,Gold(R) product with Novus International, Inc. Martek will ... of its poultry and swine feed and,enrichment products. ...
... mortality could be reduced 20% for those awaiting new ... group-incompatible heart transplants can safely be performed in infants ... death rates among infants with heart problems, say U.S. ... reported to the United Network for Organ Sharing (UNOS)from ...
... doesn,t have excess stomach acid, study finds, , , MONDAY, ... anti-reflux medications to infants, new research suggests. , The ... given anti-reflux medications, which work by lowering levels of ... four out of five infants included in the study ...
... When lean healthy young adults gained about 9 pounds, ... -- but shedding the weight restored proper functioning, according ... important because this vessel disorder, known as endothelial dysfunction, ... the effects of modest weight gain on the disorder ...
... of Premium Term, NEW YORK, Nov. 5 ... and more convenient, AXA Equitable introduced today in,approved ... Return of,Premium Term (ROP Term(SM)) life insurance on ... with Simplified Issue makes buying life,insurance easier and ...
... World-renowned heart,surgeon Dr. Rafael Espada has made history by ... Alvaro Colom, with Dr.,Espada as his running mate, won ... the country,s votes. The two will take,office January 14, ... practiced for more than 30 years,as a heart surgeon ...
Cached Medicine News:Health News:Martek Signs Exclusive Worldwide Distributorship Agreement with Novus International 2Health News:Martek Signs Exclusive Worldwide Distributorship Agreement with Novus International 3Health News:Blood-Incompatible Heart Transplants Safe for Infants 2Health News:Anti-Reflux Drugs May Be Overprescribed in Infants 2Health News:Anti-Reflux Drugs May Be Overprescribed in Infants 3Health News:Modest gain in visceral fat causes dysfunction of blood vessel lining in lean, healthy humans 2Health News:Modest gain in visceral fat causes dysfunction of blood vessel lining in lean, healthy humans 3Health News:AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 2Health News:AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 3Health News:AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 4Health News:Houston Heart Surgeon Elected Vice President of Guatemala 2
... System provides easy-to-use features, auto iris, white ... camera head construction is based on Solos ... 1-Chip Camera System, Domestic (GS 9900-NTSC) includes: ... with power cord and video cables , ...
... The 3-Chip Camera System offers 800+ ... generator, auto iris, automatic gain control, and ... , ,Complete 3-Chip Camera System for ... , (MS 1000-01) Camera Control Unit (CCU) ...
Provides a combination of concentrated cold / hot and compression for the elbow...
Provides a combination of concentrated cold / hot and compression for the neck...
Medicine Products: